---
title: "phendimetrazine - Obesity"
sidebar: mydoc_sidebar
permalink: phendimetrazineobesity4.html
toc: false 
---

{% include image.html file="phendimetrazineobesity4.png" alt="phendimetrazineobesity4" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C100294 | phendimetrazine | Drug |
| UniProt:P23975 | Sodium-dependent noradrenaline transporter | Protein |
| MESH:D009638 | norepinephrine | ChemicalSubstance |
| UBERON:0001017 | central nervous system | GrossAnatomicalStructure |
| GO:0008217 | blood pressure | BiologicalProcess |
| MESH:D009765 | Obesity | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Phendimetrazine | NEGATIVELY REGULATES | Sodium-Dependent Noradrenaline Transporter |
| Sodium-Dependent Noradrenaline Transporter | INCREASES ABUNDANCE OF | Norepinephrine |
| Norepinephrine | INCREASES ACTIVITY OF | Central Nervous System |
| Central Nervous System | POSITIVELY REGULATES | Blood Pressure |
| Blood Pressure | CORRELATED WITH | Obesity |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB01579#mechanism-of-action](https://go.drugbank.com/drugs/DB01579#mechanism-of-action){:target="_blank"}